Early outcomes of breast cancer patients treated with post-mastectomy uniform scanning proton therapy

Postmastectomy radiation therapy (PMRT) has consistently shown benefits in decreasing the risk of locoregional recurrence and increasing long-term breast cancer-specific survival and overall survival rates for high-risk node positive breast cancer [1 –3]. A standard PMRT field includes chest wall and comprehensive coverage of the axillary and supraclavicular lymph nodes. The addition of internal mammary chain in the radiation field has been increasingly adopted and supported by data from randomized clinical trials [4–6].

Source: Radiotherapy and Oncology - November 7, 2018 Category: Radiology Authors: Leo Luo, John Cuaron, Lior Braunstein, Erin Gillespie, Atif Kahn, Beryl McCormick, Dennis Mah, Brian Chon, Henry Tsai, Simon Powell, Oren Cahlon Source Type: research